After completing this activity, the reader should be better able to:
• Summarize the initial findings of the Prostate Cancer Prevention Trial.
• Explain how finasteride may affect prostate cancer detection by prostate-specific antigen testing or digital rectal examination.
• Discuss how the use of a risk calculator may be helpful for patients and their physicians when evaluating prostate cancer risk and making decisions about prevention.
To receive continuing education credit, learners must:
- Read the article in its entirety
- Take the CE self-assessment test and complete the evaluation
Please note: The learner must answer at least 70% of the questions on the post-test correctly.
The estimated time to complete this activity is 1 hour.
Your continuing education certificate can be printed by following the directions online after successful completion of the post-test and evaluation.
The University of Nebraska Medical Center,
Center for Continuing Education is accredited
by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy
education. The ACPE provider number is 447-000-08-423-
H04-P. To receive the 1 contact hour of continuing education
credit, pharmacists should complete the activity requirements
and evaluation at the conclusion of the activity.
Approval is valid from the initial release date of December 1,
2008. The expiration date is November 30, 2009. A statement
of credit will be available for printing online upon completion
of the post-test with a score of 70% or better and the evaluation
instrument.
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center (UNMC), Center for Continiung Education.
While the University of Nebraska Medical Center, Center for Continuing Education is an ACPE accredited organization, this does not imply endorsement by the UNMC or ACPE of any commercial products affiliated with this activity.